Promaxo Holdings, Inc.

Biotech Oakland, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Oakland, CA
Street
70 Washington St
Zip
94607

Offering

Total offering
$28.8M
Amount sold
$26.8M
First sale
Mar 17, 2026
Min investment
$1
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
118

How this filing compares

Ranked #4 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 5.3× the median.

Other California filings this week: 3700 Ascent LLC, 3MR JSW Mission Investors, LP, Beach Point SCF IX Loan LP, Beach Point SCF V LP, Belveron Flagship Fund VIII Investor LP

Leadership

Amit Vohra — Executive Officer (also: Director)

Michael Bartholomew — Executive Officer

Dushyant Chipalkatty — Director

Derek Hennecke — Director

Srirama Venkataraman — Executive Officer

Filing details

Promaxo Holdings, Inc. filed a Form D with the SEC on March 30, 2026.

Other newest Biotech companies

Other newest companies in California